Category Archives: Immunotherapy

A Look at the Role Monoclonal Antibodies Play in Immuno-Oncology

A Look at the Role Monoclonal Antibodies Play in Immuno-Oncology

Immuno-oncological research is exploring several different approaches to immunotherapy, including vaccines, checkpoint inhibitors, and monoclonal antibodies. At present, several different types of monoclonal antibody drugs exist, but researchers are still exploring how to employ them most effectively in a treatment plan. The term monoclonal antibody refers to a molecule produced in a laboratory that has… Read More…

A Brief Look at the History of Immuno-Oncology

A Brief Look at the History of Immuno-Oncology

In recent years, advances in immuno-oncology have generated a lot of excitement about the future of cancer care. From radical new therapies to combinations with existing approaches, the field is generating a remarkable amount of hope. While the future looks bright, it is important to understand and revisit the history of immuno-oncology, which dates back… Read More…

UCLA Researchers Find Potential Mechanism for Immunotherapy Resistance

UCLA Researchers Find Potential Mechanism for Immunotherapy Resistance

One of the biggest questions in the field of immuno-oncology is the issue of why the treatments work so effectively for some people, yet other patients experience virtually no benefit or experience tumor recurrence after the initial response. Researchers from the University of California, Los Angeles (UCLA) may have made the first step in answering… Read More…

The Parker Foundation Launches Cancer Immunotherapy Institute

Led by Silicon Valley entrepreneur and philanthropist Sean Parker, The Parker Foundation recently announced the launch of the Parker Institute for Cancer Immunotherapy. Following the recent loss of his close friend to cancer, Parker wants to figure out how to battle cancer and has particularly focused on the field of immuno-oncology. The friend whom Parker… Read More…

Can New Immunotherapy Research Halt Brain Cancer?

Can New Immunotherapy Research Halt Brain Cancer?

Recently, the National Brain Tumor Society and Oligo Nation announced a $250,000 grant that will fuel a preliminary look at immunotherapy’s applications in the treatment of oligodendroglioma, a rare brain cancer that accounts for about 6 percent of all gliomas. In the United States, there are nearly 2,000 new oligodendroglioma diagnoses each year. Since the… Read More…